sb 203580 has been researched along with kaempferol 3-o-rhamnoside in 1 studies
| Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (kaempferol 3-o-rhamnoside) | Trials (kaempferol 3-o-rhamnoside) | Recent Studies (post-2010) (kaempferol 3-o-rhamnoside) |
|---|---|---|---|---|---|
| 3,489 | 4 | 1,137 | 66 | 0 | 47 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jang, S; Jung, E; Kang, M; Kang, SH; Kim, JH; Kim, MH; Kim, MO; Lee, J; Nho, YH; Oh, SW; Park, SH | 1 |
1 other study(ies) available for sb 203580 and kaempferol 3-o-rhamnoside
| Article | Year |
|---|---|
Afzelin positively regulates melanogenesis through the p38 MAPK pathway.
Topics: Blotting, Western; Cells, Cultured; Humans; Imidazoles; JNK Mitogen-Activated Protein Kinases; Mannosides; Melanins; Melanocytes; Microphthalmia-Associated Transcription Factor; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Monophenol Monooxygenase; Oxidoreductases; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Pigmentation; Proanthocyanidins; Pyridines; Real-Time Polymerase Chain Reaction; RNA, Messenger; Signal Transduction | 2016 |